Cargando…
Checkpoint inhibitors synergize with therapeutic platforms, ZVex™ and GLAAS™ by enhancing lentiviral vector-induced tumor-specific immunity and adjuvant-mediated anti-tumor efficacy
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649483/ http://dx.doi.org/10.1186/2051-1426-3-S2-P346 |
| _version_ | 1782401367953899520 |
|---|---|
| author | Albershardt, Tina C Parsons, Andrea J ter Meulen, Jan Berglund, Peter |
| author_facet | Albershardt, Tina C Parsons, Andrea J ter Meulen, Jan Berglund, Peter |
| author_sort | Albershardt, Tina C |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4649483 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-46494832015-11-24 Checkpoint inhibitors synergize with therapeutic platforms, ZVex™ and GLAAS™ by enhancing lentiviral vector-induced tumor-specific immunity and adjuvant-mediated anti-tumor efficacy Albershardt, Tina C Parsons, Andrea J ter Meulen, Jan Berglund, Peter J Immunother Cancer Poster Presentation BioMed Central 2015-11-04 /pmc/articles/PMC4649483/ http://dx.doi.org/10.1186/2051-1426-3-S2-P346 Text en Copyright © 2015 Albershardt et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Poster Presentation Albershardt, Tina C Parsons, Andrea J ter Meulen, Jan Berglund, Peter Checkpoint inhibitors synergize with therapeutic platforms, ZVex™ and GLAAS™ by enhancing lentiviral vector-induced tumor-specific immunity and adjuvant-mediated anti-tumor efficacy |
| title | Checkpoint inhibitors synergize with therapeutic platforms, ZVex™ and GLAAS™ by enhancing lentiviral vector-induced tumor-specific immunity and adjuvant-mediated anti-tumor efficacy |
| title_full | Checkpoint inhibitors synergize with therapeutic platforms, ZVex™ and GLAAS™ by enhancing lentiviral vector-induced tumor-specific immunity and adjuvant-mediated anti-tumor efficacy |
| title_fullStr | Checkpoint inhibitors synergize with therapeutic platforms, ZVex™ and GLAAS™ by enhancing lentiviral vector-induced tumor-specific immunity and adjuvant-mediated anti-tumor efficacy |
| title_full_unstemmed | Checkpoint inhibitors synergize with therapeutic platforms, ZVex™ and GLAAS™ by enhancing lentiviral vector-induced tumor-specific immunity and adjuvant-mediated anti-tumor efficacy |
| title_short | Checkpoint inhibitors synergize with therapeutic platforms, ZVex™ and GLAAS™ by enhancing lentiviral vector-induced tumor-specific immunity and adjuvant-mediated anti-tumor efficacy |
| title_sort | checkpoint inhibitors synergize with therapeutic platforms, zvex™ and glaas™ by enhancing lentiviral vector-induced tumor-specific immunity and adjuvant-mediated anti-tumor efficacy |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649483/ http://dx.doi.org/10.1186/2051-1426-3-S2-P346 |
| work_keys_str_mv | AT albershardttinac checkpointinhibitorssynergizewiththerapeuticplatformszvexandglaasbyenhancinglentiviralvectorinducedtumorspecificimmunityandadjuvantmediatedantitumorefficacy AT parsonsandreaj checkpointinhibitorssynergizewiththerapeuticplatformszvexandglaasbyenhancinglentiviralvectorinducedtumorspecificimmunityandadjuvantmediatedantitumorefficacy AT termeulenjan checkpointinhibitorssynergizewiththerapeuticplatformszvexandglaasbyenhancinglentiviralvectorinducedtumorspecificimmunityandadjuvantmediatedantitumorefficacy AT berglundpeter checkpointinhibitorssynergizewiththerapeuticplatformszvexandglaasbyenhancinglentiviralvectorinducedtumorspecificimmunityandadjuvantmediatedantitumorefficacy |